Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers

Clinical trial NCT01843725 · COMPLETED

Trial details

NCT number: NCT01843725
Sponsor: Jules Bordet Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Cancers Metastatic Gastric Cancers Metastatic Oesophageal Cancers Metastatic Pancreatic Cancers Metastatic Biliary Cancers Metastatic Breast Cancers

Start date: 2013-09-01
Primary completion: 2016-10-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.